Epoxyeicosatrienoic acids contribute with altered nitric oxide and endothelin-1 pathways to conduit artery endothelial dysfunction in essential hypertension.

Epoxyeicosatrienoic acids contribute with altered nitric oxide and endothelin-1 pathways to conduit artery endothelial dysfunction in essential hypertension.

Item
http://www.wikidata.org/entity/Q38474740
Impact of soluble epoxide hydrolase and epoxyeicosanoids on human healthThe role of epoxyeicosatrienoic acids in the cardiovascular systemInducible endothelium-derived hyperpolarizing factor: role of the 15-lipoxygenase-EDHF pathwayEpoxyeicosatrienoic acids, hypertension, and kidney injuryRescue of hypertension-related impairment of angiogenesis by therapeutic ultrasound.Redundant vasodilator pathways underlying radial artery flow-mediated dilation are preserved in healthy aging.Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice.Cilostazol suppresses angiotensin II-induced apoptosis in endothelial cells.Novel relationships of markers of monocyte activation and endothelial dysfunction with pulmonary dysfunction in HIV-infected persons.Endogenous endothelin-1 and femoral artery shear rate: impact of age and implications for atherosclerosis.Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseases.Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established: a study in Cyp1a1-Ren-2 transgenic rats.A sensitive LC-MS/MS method for the quantification of regioisomers of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids in human plasma during endothelial stimulation.Role of Toll-like receptors 2 and 4 in mediating endothelial dysfunction and arterial remodeling in primary arterial antiphospholipid syndrome.High-efficiency on-line haemodiafiltration improves conduit artery endothelial function compared with high-flux haemodialysis in end-stage renal disease patients.
P2860

Epoxyeicosatrienoic acids contribute with altered nitric oxide and endothelin-1 pathways to conduit artery endothelial dysfunction in essential hypertension.

Item
http://www.wikidata.org/entity/Q38474740
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Epoxyeicosatrienoic acids cont ...... ion in essential hypertension.
@en
type
label
Epoxyeicosatrienoic acids cont ...... ion in essential hypertension.
@en
prefLabel
Epoxyeicosatrienoic acids cont ...... ion in essential hypertension.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Epoxyeicosatrienoic acids cont ...... ion in essential hypertension.
@en
P2093
P304
P31
P356
10.1161/CIRCULATIONAHA.111.070680
P407
P433
P478
P577
P698
P921